Related Experiment Video
Updated: Aug 9, 2026

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
Published on: May 17, 2024
Coronary heart disease in treated hypertensive patients and risk-matched normotensive control subjects
Insights
Antihypertensive therapy may not significantly reduce coronary heart disease (CHD) in hypertensive men, and shows no benefit for women. Further research is needed to confirm effects of blood pressure treatment on cardiovascular health.
Area of Science:
- Cardiology
- Hypertension Research
- Epidemiology
Background:
- Coronary heart disease (CHD) remains a leading cause of mortality globally.
- Hypertension is a major modifiable risk factor for CHD.
- The effectiveness of antihypertensive therapy in reducing CHD incidence requires ongoing investigation.
Purpose of the Study:
- To prospectively assess the incidence of coronary heart disease (CHD) in treated hypertensive patients compared to normotensive controls.
- To determine if antihypertensive therapy influences CHD rates based on predicted risk.
- To investigate potential sex-based differences in the treatment effect of antihypertensive therapy on CHD.
Main Methods:
- Prospective cohort study involving 543 participants (335 hypertensive, 208 normotensive controls).
- Individual matching of controls to hypertensive subgroup based on seven risk factors.
- Comparison of observed CHD incidence against rates predicted by initial and post-treatment blood pressure levels.
Main Results:
- In hypertensive men, CHD incidence aligned with post-treatment blood pressure predictions, but the reduction was not statistically significant.
- CHD incidence in hypertensive women exceeded post-treatment predictions, with normotensive controls showing a lower-than-expected rate.
- A potential treatment effect in hypertensive men could not be confirmed due to lack of statistical significance and similarity to control group trends.
Conclusions:
- Antihypertensive therapy did not demonstrate a statistically significant reduction in CHD incidence in the studied hypertensive population.
- No evidence of a protective treatment effect was found in hypertensive women.
- Sex-specific differences in response to antihypertensive therapy regarding CHD incidence warrant further investigation.
Abstract:
The incidence of coronary heart disease (CHD) was recorded prospectively for 543 persons--335 treated hypertensive patients and a group of 208 normotensive control subjects, individually matched to a subgroup of the hypertensive patients on the basis of seven risk factors. If antihypertensive therapy reduces CHD, CHD should have occurred at a rate predicted by initial blood pressure levels in the normotensive control subjects and at a rate predicted by post-treatment blood pressure levels in the hypertensive patients. A treatment effect seemed possible in hypertensive men, since CHD occurred at the rate predicted by post-treatment blood pressure levels. However, because the reduction was not statistically significant and was similar to a reduction observed in the normotensive control subjects, a treatment effect could not be confirmed. There was no evidence of a treatment effect in hypertensive women, since CHD occurred at a rate higher than that predicted by post-treatment blood pressure levels and the normotensive control subjects showed a lower than expected rate.
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Coronary Artery Disease IV: Preventive Measures
Hypertension I: Introduction
Hypertension II: Pathophysiology
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension IV: Drug Therapy and Lifestyle Modifications
